Similar articles for PMID: 29891203

Year	Number of Results
1998	2
2001	1
2004	1
2005	5
2006	3
2007	2
2008	2
2009	4
2010	2
2011	10
2012	16
2013	15
2014	5
2015	17
2016	19
2017	23
2018	21
2019	26
2020	16
2021	14
2022	14
2023	3
2024	0

1

Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer.

Bryant AK, Kader AK, McKay RR, Einck JP, Mell LK, Mundt AJ, Kane CJ, Efstathiou JA, Murphy JD, Rose BS. Bryant AK, et al. Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1188-1193. doi: 10.1016/j.ijrobp.2018.04.023. Epub 2018 Apr 17. Int J Radiat Oncol Biol Phys. 2018. PMID: 29891203

2

Androgen deprivation with or without radiation therapy for clinically node-positive prostate cancer.

Lin CC, Gray PJ, Jemal A, Efstathiou JA. Lin CC, et al. J Natl Cancer Inst. 2015 May 9;107(7):djv119. doi: 10.1093/jnci/djv119. Print 2015 Jul. J Natl Cancer Inst. 2015. PMID: 25957435

3

Six-month androgen suppression plus radiation therapy compared with radiation therapy alone for men with prostate cancer and a rapidly increasing pretreatment prostate-specific antigen level.

D'Amico AV, Loffredo M, Renshaw AA, Loffredo B, Chen MH. D'Amico AV, et al. J Clin Oncol. 2006 Sep 1;24(25):4190-5. doi: 10.1200/JCO.2006.06.8239. J Clin Oncol. 2006. PMID: 16943536

4

Association between Radical Prostatectomy and Survival in Men with Clinically Node-positive Prostate Cancer.

Sarkar RR, Bryant AK, Parsons JK, Ryan ST, Karim Kader A, Kane CJ, McKay RR, Sandhu A, Murphy JD, Rose BS. Sarkar RR, et al. Eur Urol Oncol. 2019 Sep;2(5):584-588. doi: 10.1016/j.euo.2018.09.015. Epub 2018 Oct 19. Eur Urol Oncol. 2019. PMID: 31411995 Free PMC article.

5

The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy.

Dong Y, Ruth KJ, Churilla TM, Viterbo R, Sobczak ML, Smaldone MC, Chen DY, Uzzo RG, Hallman MH, Horwitz EM. Dong Y, et al. Can J Urol. 2017 Feb;24(1):8656-8662. Can J Urol. 2017. PMID: 28263132

6

The impact of timing of salvage hormonal therapy on survival after brachytherapy for prostate cancer.

Sagalovich D, Leapman M, Sfakianos J, Hall S, Stock R, Stone N. Sagalovich D, et al. Brachytherapy. 2016 Nov-Dec;15(6):730-735. doi: 10.1016/j.brachy.2016.09.005. Epub 2016 Oct 12. Brachytherapy. 2016. PMID: 27743956

7

The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.

Bianchi L, Nini A, Bianchi M, Gandaglia G, Fossati N, Suardi N, Moschini M, Dell'Oglio P, Schiavina R, Montorsi F, Briganti A. Bianchi L, et al. Eur Urol. 2016 Jun;69(6):1142-8. doi: 10.1016/j.eururo.2015.12.010. Epub 2015 Dec 31. Eur Urol. 2016. PMID: 26749093

8

Posttreatment Prostate-Specific Antigen 6 Months After Radiation With Androgen Deprivation Therapy Predicts for Distant Metastasis-Free Survival and Prostate Cancer-Specific Mortality.

Naik M, Reddy CA, Stephans KL, Ciezki JP, Garcia J, Grivas P, Stephenson AJ, Klein EA, Tendulkar RD. Naik M, et al. Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):617-23. doi: 10.1016/j.ijrobp.2016.07.009. Epub 2016 Jul 17. Int J Radiat Oncol Biol Phys. 2016. PMID: 27681757

9

Short-term androgen-deprivation therapy improves prostate cancer-specific mortality in intermediate-risk prostate cancer patients undergoing dose-escalated external beam radiation therapy.

Zumsteg ZS, Spratt DE, Pei X, Yamada Y, Kalikstein A, Kuk D, Zhang Z, Zelefsky MJ. Zumsteg ZS, et al. Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1012-7. doi: 10.1016/j.ijrobp.2012.07.2374. Epub 2012 Sep 14. Int J Radiat Oncol Biol Phys. 2013. PMID: 22981709

10

Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer.

Fischer-Valuck BW, Rao YJ, Brenneman RJ, Patel PR, Filson CP, Jani AB, Liu Y, Goyal S, Xu K, Weiss A, Kucuk O, Cimmino C, Szabo S, Rossi P, Baumann BC, Pattaras J, Hershatter B, Patel SA. Fischer-Valuck BW, et al. Brachytherapy. 2020 Sep-Oct;19(5):557-566. doi: 10.1016/j.brachy.2020.05.007. Epub 2020 Jul 3. Brachytherapy. 2020. PMID: 32624405

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

175 results

Results by year